Evotek to Partner With Ozempic Maker Novo Nordisk on Stem Cell Therapy
Novo Nordisk AS Class B NOV
News
Trending: Novo Nordisk Faces Senate Over Ozempic, Wegovy Pricing
Novo Nordisk CEO spars with lawmakers over Ozempic, Wegovy prices
Skye Bioscience Shares Gain After Highlighting Safety of In-Development Obesity Treatment
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also 'on notice'
Novo Nordisk Experimental Obesity Pill Achieved Limited Extra Weight-Loss at Higher Doses
Novo Nordisk's Wegovy Gets EU Backing to Treat Obesity-Related Heart Failure
Novo Nordisk's Ozempic Likely to Face U.S. Price Negotiations, Bloomberg Reports
Novo Nordisk's Experimental Obesity Pill Could Be More Effective With Extended Use
Obesity drugs in kindergarten? Novo Nordisk GLP-1 drug works for kids as young as 6, study finds.
Eli Lilly's weekly insulin intensifies race with Novo Nordisk
Obesity drugs' next wave: These companies could snag 20% of GLP-1 market, analysts say
Eli Lilly's Mounjaro cuts risk of developing Type 2 diabetes, study finds
Ozempic and Wegovy use among patients with depression needs more scrutiny, researchers say
Medicare's negotiated drug prices will save taxpayers $6 billion in first year, White House says
Norway sovereign wealth fund leans on tech as it trims Meta, Novo Nordisk stakes
Should you invest in a hedged ETF?
Novo Nordisk Down Nearly 7%, on Pace for Largest Percent Decrease Since August 2022 — Data Talk
Ozempic maker Novo Nordisk misses profit estimates as it builds out capacity
Novo Nordisk's Wegovy Sales Disappoint — 2nd Update
United States